VEREGEN

This brand name is authorized in United States. It is also authorized in Canada, Croatia, Estonia, Lithuania, Netherlands, Romania.

Active ingredients

The drug VEREGEN contains one active pharmaceutical ingredient (API):

1
UNII T432289GYZ - SINECATECHINS
 
Read more about Sinecatechins

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 VEREGEN Ointment MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D06BB12 Sinecatechins D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02411849
EE Ravimiamet 1660193, 1660205
HR Agencija za lijekove i medicinske proizvode HR-H-677936277
LT Valstybinė vaistų kontrolės tarnyba 1074089, 1077677
NL Z-Index G-Standaard, PRK 103543
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W59290001, W59290002
US FDA, National Drug Code 10337-450

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.